Clinical Trials Logo

Filter by:
NCT ID: NCT02535910 Enrolling by invitation - Clinical trials for Cardiovascular Diseases

Effect of vitaminD3 or 25(OH)D3 Fortified Dairy on Vitmain D Status and CVD Risk Markers

Start date: August 2015
Phase: N/A
Study type: Interventional

This study aims to compare the acute effect of consuming milk and butter fortified with either vitamin D3 or 25 (OH) D3 on serum/plasma vitamin D status in humans. In addition, the effect of vitamin D3 or 25 (OH) D3 in milk and butter on certain CVD risk markers and cognitive function will be examined.

NCT ID: NCT02517333 Enrolling by invitation - Dyspraxia Clinical Trials

Exploring the Impact and Feasibility of a Pathway to Sport and Long-term Participation in Young People

EPIC
Start date: March 2014
Phase: N/A
Study type: Interventional

The importance of play and physical activity include its many benefits on positively improving health and well-being, enhancing children's and young people's thinking and performance in school, improving their sleep and enabling confidence and skill building (Janssen and LeBlanc, 2010; Budde et al., 2008; Sallis and Patrick, 1994). However, children with movement difficulties (MD) and physical disabilities are at risk of decreased physical activity and subsequently decreased physical fitness and overall health and well-being as a result. To build upon current findings and to follow-up on a continuing study, looking at the impact (responses) and recovery during and following acute exercise at different intensities in children and adolescents with and without movement difficulties, this next phase aims to provide an intervention to improve fitness levels and health measures and to strategically provide a pathway for longer term participation in physical activity in young people. Implement and evaluate a pathway to sport for 14+ year old young people who do not regularly participate in sport due to Neurodevelopmental conditions, young people presenting with poor coordination and movement, and even children and adolescents with special educational needs. The pathway hopes to promote engagement, participation, inclusion and confidence (EPIC) in sport within local schools and the community through 1) targeted recruitment, 2) confidence and skill building (EPIC Club), 3) connection to sport ('Have a go days') and 4) exit to long term participation.

NCT ID: NCT02485223 Enrolling by invitation - Multiple Sclerosis Clinical Trials

Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis

STAR-MS
Start date: May 2015
Phase: N/A
Study type: Observational

This is a pilot study (a small scale study testing procedures so that the investigators can apply this to a larger scale study). This study will test the accuracy of a new brain scan (Magnetic Resonance Imaging) technique in predicting the diagnosis of multiple sclerosis (MS) in patients where there is uncertainty about the diagnosis. For patients where there is a suspicion (but not definite) diagnosis of MS, an additional MRI brain scan will be offered. There will be no other research tests and the patient is followed up to see what the eventual diagnosis is. The investigators will then review the original brain scan to see if this predicted the diagnosis of MS or not.

NCT ID: NCT02430363 Enrolling by invitation - Glioblastoma Clinical Trials

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Start date: March 2013
Phase: Phase 1/Phase 2
Study type: Interventional

It is known that after application of MK-3475 activated PD -1 negatively regulates the activation of T cells through suppression of the path of PI3K / Akt. This study will identify the effectiveness of oral inhibitors of PI3K / Akt pathway in comparison with MK-3475 (pembrolizumab).

NCT ID: NCT02360384 Enrolling by invitation - Clinical trials for Irritable Bowel Syndrome

Caecal pH as a Biomarker for Irritable Bowel Syndrome

Start date: November 2015
Phase: N/A
Study type: Interventional

Irritable bowel syndrome is common. Currently, it is a diagnosis of exclusion. There is increasing evidence of the importance of the microbiota in the pathophysiology of this disorder. However, it has been challenging to measure the "activity" of the microbiota in vivo as much of the GI tract is inaccessible. Fermentation by the microbiota occurs in the colon, a by product of which are short chain fatty acids. Measuring pH in the colon could potentially act as a surrogate marker of fermentation. The investigators are undertaking a randomised controlled trial in patients with IBS measuring the pH in the digestive tract using a wireless motility capsule at baseline and in response to dietary changes in patients with diarrhoea predominant IBS and in response to linaclotide in those with constipation predominant IBS to ascertain the effect of these interventions on the microbiota and clinical outcomes.

NCT ID: NCT02306720 Enrolling by invitation - Clinical trials for Hypophosphatasia (HPP)

Registry of Patients With Hypophosphatasia

Start date: April 2, 2017
Phase:
Study type: Observational [Patient Registry]

In this prospective, observational, long term registry patients of all ages with a diagnosis of hypophosphatasia (HPP) are followed at participating sites in multiple countries.

NCT ID: NCT02267902 Enrolling by invitation - Healthy Clinical Trials

Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229

Start date: September 2014
Phase: Phase 1
Study type: Interventional

The objectives of this study are to evaluate the absolute bioavailability, and absorption and excretion of DA-1229, an IMP in clinical assessment for the treatment of T2DM. The oral and IV PK of DA-1229 will also be evaluated. The metabolism of DA-1229 may also be evaluated.

NCT ID: NCT02174354 Enrolling by invitation - Psoriasis Chronic Clinical Trials

Methotrexate Polyglutamates as a Marker of Clinical Response and Toxicity in the Treatment of Psoriasis

MTXPG
Start date: January 2011
Phase: N/A
Study type: Observational

Methotrexate (MTX) is widely prescribed to treat inflammatory conditions including psoriasis, where it is the recommended first-line systemic therapy in moderate-to-severe disease. Approximately 40% of patients with psoriasis have a sub-optimal response to MTX and a significant number experience side effects that may include deranged liver enzymes. There is currently no validated test to predict how patients with psoriasis will respond to MTX, in terms of disease outcome and/or toxicity, or to guide dose escalation in this group.

NCT ID: NCT02153515 Enrolling by invitation - Dry Eyes Clinical Trials

Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous Blood

FAB
Start date: April 2014
Phase: Phase 3
Study type: Interventional

To investigate if fresh finger prick autologous blood (FAB) instead of serum from venesection, is a safe and effective treatment for dry eyes and corneal ulcers/ epithelial defects. Currently there are no studies on the use of whole fresh blood for the treatment of chronic ulcers, persistent epithelial defects or dry eyes. Unpublished case reports indicate that fresh blood can be an effective tool to the treatment of corneal pathology.

NCT ID: NCT02098070 Enrolling by invitation - Knee Osteoarthritis Clinical Trials

Knee Pain Phenotypes in the Community Study

Start date: September 2014
Phase: N/A
Study type: Observational

The focus of the study is to determine the prevalence and variance of self-reported knee pain characteristics in a community-derived sample of adults aged 40 years and over. It will also identify characteristics such as structural changes of osteoarthritis of the knee as well as physiological parameters and blood and urine biomarkers.